LifeVantage Corporation (NASDAQ:LFVN) Q2 2026 Earnings Call Transcript February 4, 2026 LifeVantage Corporation misses on earnings expectations. Reported EPS is $0.05257 EPS, expectations were $0.22.

SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the ...

LifeVantage Corporation (LFVN) reported its Q2 FY2026 earnings, meeting EPS expectations but missing revenue forecasts. The company reported an EPS of $0.15, aligning with projections, while revenue ...

SALT LAKE CITY, Jan. 12, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level ...

LifeVantage Corporation beats earnings expectations. Reported EPS is $0.18, expectations were $0.17. Operator: Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to today’s ...

LifeVantage reported revenue growth of 12.6% in Q4 and a 21.4% year-over-year increase in adjusted EPS in Q4. International markets returned to growth for the first time in nearly three years during ...

Let me help you build a custom plan using TrueScience Collagen, Protandim Nrf2 and advanced in-clinic treatments. If you’re feeling overwhelmed by the number of collagen products on the market, you’re ...

LifeVantage leads in nutrigenomics, focusing on how nutrition impacts gene expression for optimal health. LifeVantage projections indicate a strong 26.6% EPS CAGR through 2027, driven by high-margin ...

LifeVantage hosted its Activate 2025 virtual event, launching the "Summer in the Fast Lane" campaign for Consultant engagement and incentives. LifeVantage Corporation hosted its global Activate 2025 ...